Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. The higher of two doses of brepocitinib improved ...

Posts with #TSW have had over a billion views on TikTok, sparking research into this mystery skin condition.

At 52 weeks, the 30-mg daily oral dose of brepocitinib outperformed the 15-mg dose in a study of patients with dermatomyositis resistant to previous treatments.

Oral brepocitinib 30 mg was superior to placebo for treating dermatomyositis in adults already receiving standard therapies, according to phase 3 data presented at the American Academy of Dermatology ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Verstappen has said he'd consider his options if it wasn't fun to drive the cars in 2026. And it doesn't seem like he's having fun.

What’s the best way to manage your cholesterol? Drawing on decades of research, a world-leading heart-health doctor explains what works ...

Teenagers often smell weird to their parents, but it's not their fault. Rather, there's a biological reason, which might also ...

Amid a wave of complaints from F1 four-time world champion Max Verstappen, ESPN's Nate Saunders examines every one and gives ...

Welcome to spring. It might not feel like it, but soon, trees and bushes will be in full bloom, and flowers will be everywhere. If you suffer from seasonal allergies — also known as allergic rhinitis ...